GlassScriptPhysician profile
Sterling M Riddley
NPI 1902288111
$982.76
in general payments reported to CMS, 2019-2025
12 companies · $378 in 2025
The $378 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2021: $70.42 · 2022: $105 · 2023: $106 · 2024: $54.24 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $506 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $505.82 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $250.84 | 2022-2025 | Ozempic, Rybelsus |
| Insulet Corporation | $215.50 | 2019-2022 | |
| Medtronic Minimed, INC. | $165.40 | 2019 | |
| Corcept Therapeutics | $161.41 | 2024-2025 | Korlym |
| Ascensia Diabetes Care US INC. | $39.73 | 2025 | |
| Sequel Med Tech, LLC | $32.24 | 2025 | Twiist |
| Beta Bionics, INC. | $25.54 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Merck Sharp & Dohme LLC | $21.25 | 2024 | Capvaxive, Vaxelis, Gardasil 9 |
| Dexcom, INC. | $19.95 | 2023 | Dexcom G6 Transmitter |
| Pfizer INC. | $18.62 | 2023 | |
| Abbott Laboratories | $16.67 | 2022 | |
| Tandem Diabetes Care, INC. | $15.61 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sterling Riddley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.